This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, for the delivery of Bupropion HCL XL 300 mg tablets. The Delivery Order contract, valued at $1,049.56, has a firm fixed price and an ultimate completion date of May 8, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
The contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts, particularly for the Department of Defense and Veterans Affairs healthcare systems.
Generated 8/6/24, 11:18 AM